It is low density lipoprotein (LDL), the major cholesterol-rich lipoprotein, which accounts for the link between increasing plasma cholesterol and coronary heart disease risk. Although once considered to be homogeneous it has become clear that LDL comprises a spectrum of particles.
resembling LDL-III. Kinetic studies suggest that VLDL 1 (Svedberg flotation units (Sf) 60-400) particles, which are present in hypertriglyceridaemia, give rise to LDL-III particles whereas the smaller VLDL 2 (Sf 20-60) found in normal and hypercholesterolaemic individuals gives rise to LDL-II particles. Enhanced postprandial lipaemia is probably also an important determinant of the production of small dense LDL [15] .
LDL subclasses and atherogenicity
Whether small dense LDL are directly atherogenic remains to be fully proven. However, the literature points to several possible mechanisms whereby small dense LDL may be atherogenic including increased infiltration into the arterial wall [16] . Increased sequestration due to enhanced binding to arterial proteoglycans [17, 18] possibly related to conformational changes in apoprotein B [19] and reduced carbohydrate and sialic acid content [20] has been reported. Increased susceptibility to oxidation has also been reported for small dense LDL [21] .
LDL subclass distribution in insulin resistance and non-insulin-dependent diabetes mellitus (NIDDM)
Hypertriglyceridaemia often associated with low HDL cholesterol concentration is a common finding in NIDDM and often persists despite best efforts at glycaemic control. Several studies have pointed to the strong relationship between triglycerides and coronary heart disease risk and this relationship may be explained in part by abnormal postprandial lipaemia, the accumulation of remnant particles and a shift in the LDL distribution towards small dense particles [22] .
In a group of poorly controlled, obese NIDDM patients with hypertriglyceridaemia a reduction in intermediate density LDL and a concomitant increase in small, dense LDL was observed [ Hypertriglyceridaemia has a major impact on LDL concentrations in the non-diabetic population [31] and this is also the case in NIDDM [27, 32] . In the fasting state multivariate analysis showed that fasting triglyceride concentrations, HDL cholesterol and hepatic lipase activity were the most important determinants of LDL-III (R 2 = 67 %). Postprandially, chylomicron remnant clearance, hepatic lipase activity and insulin resistance were the major determinants of LDL-III (R 2 = 61 %) [27] . The mechanisms explaining the link between insulin resistance and LDL heterogeneity remain to be fully elucidated. However, it is known that insulin resistance is associated with increased non-esterified fatty acid flux to the liver, increased hepatic output of large VLDL which is not suppressed postprandially, increased postprandial lipaemia, increased activity of hepatic lipase and increased CETP activity. All these factors would tend to favour the formation of small dense LDL-III particles. Fig. 1 . Distribution of human plasma LDL subclass density and particle size. *LDL: subclass density profiles obtained by density gradient ultracentrifugation and representative of a typical normal, healthy female (---), male (-• -) and CAD patient (--) ***LDL: particle size as determined by 2-16 % gradient gel electrophoresis. Reproduced from reference [33] 4. Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease. 
